LUCD — Lucid Diagnostics Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1799011 ·
Last close
$0.40
Market Cap
$77.69M
52W High
$1.63
52W Low
$0.30
ADV30
9,396,622
Next earnings
2026-11-12
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,203,000 -201,000 -12,276,000 -6,677,000 27,857,000 17,993,000 21,925,000
Jun 2026 1,474,000 29,000 -12,801,000 -11,687,000 38,946,000 33,404,000 28,019,000
Mar 2026 1,256,000 -369,000 -12,114,000 -13,909,000 34,080,000 27,876,000 30,080,000
Dec 2025 1,504,000 -356,000 -14,011,000 -16,266,000 40,445,000 34,705,000 29,509,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-51,526,000
Investing CF
$-304,000
Financing CF
$22,491,000
CapEx
$-304,000
Dividends Paid
—
Buybacks
$-21,000
EPS Diluted TTM
$-0.38
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-319,355,000
Inventory
$520,000
Receivables
$843,000
ST Investments
—
EBIT TTM
$-48,522,000
Pretax Income TTM
$-48,539,000
Interest Exp TTM
$17,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,436,000
EBITDA
$-50,321,000
Free Cash Flow
$-30,776,250
Enterprise Value
$86,901,168
Total Cash
$19,029,000
Total Debt
$18,487,000
Shares Out
194,707,560
Trailing EPS
$-0.36
Book Value
$0.03
ROE
-305.6%
ROA
-79.0%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 4,706,000 -49,640,000 -58,010,000 40,445,000 29,509,000 10,936,000 -46,485,000
Dec 2024 4,346,000 -46,052,000 -45,529,000 30,715,000 25,324,000 5,391,000 -44,140,000
Dec 2023 2,428,000 -48,482,000 -52,666,000 27,270,000 29,581,000 -2,311,000 -32,817,000
Dec 2022 377,000 -56,251,000 -56,171,000 32,509,000 9,462,000 23,047,000 -29,685,000

TTM Snapshot

Revenues TTM
$5,445,000
NetIncome TTM
$-52,259,000
OpCashFlow TTM
—
Assets (Latest)
$38,946,000
Forward EPS
$-0.17

Peers — same industry

TickerNameMarket CapLastDaily %
RTGN RetinalGenix Technologies Inc. $75.19M $3.99 —
LAKE LAKELAND INDUSTRIES INC $82.33M $8.29 —
EBRCZ EBR Systems, Inc. $70.01M $0.08 —
STXS Stereotaxis, Inc. $88.39M $0.88 —
APT ALPHA PRO TECH LTD $68.25M $6.65 —

News headlines (Yahoo Finance, 1h cache)

PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results
2026-11-13 13:00 · Yahoo
Lucid Diagnostics Inc (LUCD) Q3 2026 Earnings Call Highlights: Medicare Reimbursement ...
2026-11-12 23:06 · Yahoo
What Lucid Diagnostics (LUCD) Said on Its Q3 Earnings Call
2026-11-12 20:14 · Yahoo
Lucid Diagnostics Inc. Q3 2026 Earnings Call Summary
2026-11-12 17:54 · Yahoo
Lucid Diagnostics (LUCD) Q3 2026 Earnings Call Transcript
2026-11-12 15:59 · Yahoo
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates
2026-11-12 13:15 · Yahoo
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results
2026-11-12 13:00 · Yahoo
Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year
2026-11-05 13:25 · Yahoo
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
2026-11-04 13:55 · Yahoo
Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study
2026-11-03 13:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.